Efficacy and Safety of Naftopidil in Patient With Neurogenic Lower Urinary Tract Dysfunction Not Caused by Benign Prostatic Hyperplasia

Trial Profile

Efficacy and Safety of Naftopidil in Patient With Neurogenic Lower Urinary Tract Dysfunction Not Caused by Benign Prostatic Hyperplasia

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Naftopidil (Primary) ; Tamsulosin
  • Indications Neurogenic bladder
  • Focus Therapeutic Use
  • Most Recent Events

    • 12 Feb 2015 Planned End Date changed from 1 Mar 2015 to 1 Apr 2015 as per ClinicalTrials.gov record.
    • 12 Feb 2015 Planned primary completion date changed from 1 Mar 2015 to 1 Apr 2015 as per ClinicalTrials.gov record.
    • 12 Feb 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top